ANCA-IgG-positive ANCA Associated Vasculitis

Clinical trial pipeline · Data from ClinicalTrials.gov

See which ANCA-IgG-positive ANCA Associated Vasculitis trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

Not Yet RecruitingPhase 1/2

NCT06590545

Anti-CD 19 CAR-T Cell Therapy in Patients With ANCA Vasculitis

The goal of this phase I/II clinical trial is to investigate anti-CD 19 chimeric antigen receptor T cell (CAR-T cell) therapy in patients with antineutrophil cy…

Location not specified8 participantsStarted 2025-01

Treatment: KYV-101, an autologous fully-human anti-CD19 CAR T-cell immunotherapy